Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antineoplastic agent
anthracycline antibiotic |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:affiliatedWith |
antibiotics
antineoplastic agents |
| gptkbp:alsoKnownAs |
gptkb:doxorubicin
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01DB01
|
| gptkbp:CASNumber |
23214-92-8
|
| gptkbp:chemicalFormula |
C27H29NO11
|
| gptkbp:discoveredBy |
gptkb:Farmitalia
|
| https://www.w3.org/2000/01/rdf-schema#label |
hydroxydaunorubicin
|
| gptkbp:mechanismOfAction |
inhibits topoisomerase II
intercalates DNA |
| gptkbp:molecularWeight |
543.52 g/mol
|
| gptkbp:sideEffect |
nausea
hair loss cardiotoxicity myelosuppression |
| gptkbp:usedFor |
gptkb:cancer
gptkb:rhabdomyosarcoma leukemia bladder cancer |
| gptkbp:bfsParent |
gptkb:Adriamycin
gptkb:doxorubicin |
| gptkbp:bfsLayer |
7
|